한글목차

RWE(Real-World Evidence) 솔루션 동향 및 전망

세계 RWE(Real-World Evidence) 솔루션 시장의 미래는 헬스케어 기업, 헬스케어 지불자, 헬스케어 제공자 시장에서의 기회로 인해 유망한 전망을 보이고 있습니다. 세계 리얼월드 에비던스 솔루션 시장은 2024년부터 2030년까지 연평균 8.1%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 실제 세계 증거(RWE) 능력 향상에 대한 생명과학 산업의 수요 증가, 만성질환 및 암 발생률 증가, 실용적인 증거 솔루션을 위한 첨단 기술 사용 증가 등입니다.

• Lucintel은 용도별로는 예측 기간 동안 의약품 개발 및 승인 부문이 가장 큰 부문을 차지할 것으로 예상하고 있습니다.
• 최종 사용처별로는 의약품 승인 절차에서 리얼월드 증거 연구의 중요성이 높아짐에 따라 헬스케어 기업이 가장 큰 비중을 차지할 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 큰 지역으로 남을 것이며, 이는 실제 증거 서비스 제공업체 수가 증가하고 정부 규제가 양호하기 때문으로 분석됩니다.

RWE(Real-World Evidence) 솔루션 시장의 전략적 성장 기회

RWE 솔루션 시장은 주요 애플리케이션에서 몇 가지 전략적 성장 기회를 제공하고 있습니다. 이러한 기회를 활용하면 의사결정을 강화하고 의료 성과를 개선할 수 있습니다.

• 환자 중심 솔루션 강화 : 환자 중심 솔루션 강화는 큰 성장 기회입니다. 여기에는 환자가 보고한 결과와 경험을 수집하고 분석하는 데 중점을 둔 도구와 플랫폼을 구축하는 것이 포함됩니다. 이러한 솔루션은 치료 효과와 환자 만족도에 대한 귀중한 인사이트를 제공하여 개인화된 치료를 개선할 수 있도록 돕습니다.
• 고급 분석 플랫폼 : 빅데이터, AI, 머신러닝을 활용한 고급 분석 플랫폼을 확장할 수 있는 기회가 있습니다. 이러한 플랫폼은 보다 진보된 데이터 분석 및 예측 기능을 제공하여 헬스케어 이해관계자들이 실제 데이터에서 실행 가능한 인사이트를 도출하고 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
• 통합 데이터 생태계 : 통합 데이터 생태계 구축은 전자의무기록, 청구 데이터, 웨어러블 기기 등 다양한 소스의 데이터를 결합하여 성장 기회를 제공합니다. 이러한 통합은 RWE의 포괄성과 정확성을 향상시켜 더 나은 의사결정과 정책 수립을 지원합니다.
• 규제 컨설팅 서비스 : RWE에 초점을 맞춘 규제 컨설팅 서비스 제공은 성장 잠재력을 가지고 있습니다. 규제 기관이 점점 더 많은 실제 데이터를 의사결정에 도입함에 따라 규제 요건을 탐색하고 규정 준수를 보장하기 위한 전문 지식이 필요합니다. 컨설팅 서비스는 조직이 RWE를 효과적으로 활용하여 규제 당국의 승인 신청 및 승인에 활용할 수 있도록 도와줍니다.
• 데이터 공유를 위한 협업 플랫폼 : 의료 서비스 제공자, 연구자 및 기술 기업 간의 데이터 공유를 위한 협업 플랫폼의 개발은 전략적 기회입니다. 이러한 플랫폼은 실제 데이터 교환을 촉진하고, 공동 연구 이니셔티브를 촉진하며, 혁신적인 RWE 솔루션 개발을 강화할 수 있습니다.

RWE 솔루션 시장의 전략적 성장 기회에는 환자 중심 솔루션 강화, 고급 분석 플랫폼, 통합 데이터 생태계, 규제 컨설팅 서비스, 데이터 공유를 위한 협업 플랫폼 등이 포함됩니다. 이러한 기회는 RWE 솔루션의 개발 및 적용을 지원하고 시장 확대와 의료 의사결정 개선을 촉진할 수 있습니다.

실증 솔루션 시장 활성화 요인 및 과제

RWE(Real-World Evidence) 솔루션 시장은 기술 발전, 경제적 요인, 규제적 고려사항 등 다양한 시장 촉진요인과 과제에 영향을 받습니다. 이러한 요소들은 시장 역학을 형성하고 RWE 솔루션의 개발 및 채택에 영향을 미칩니다.

RWE 솔루션 시장의 촉진요인은 다음과 같습니다.

• 기술 발전 : 빅데이터 분석, 머신러닝, 인공지능 등 기술 발전 속도가 빨라지면서 대량의 실제 데이터를 분석할 수 있는 능력이 향상되었습니다. 이러한 도구는 보다 정확한 해석을 가능하게 하고 더 나은 의사결정과 개별화 치료로 이어지는 인사이트를 제공합니다. 기술이 발전함에 따라 서로 다른 데이터 소스를 통합하고 함께 분석할 수 있게 되어 RWE 솔루션이 더욱 견고해질 것입니다.
• 규제 당국의 지원 및 프레임워크 : 실제 증거를 의사결정 과정에 포함시켜야 한다는 규제 당국의 인식이 확산되고 있는 것이 그 원동력입니다. 예를 들어, FDA와 EMA는 의약품 승인 및 시장 평가에 RWE를 통합하는 것을 목표로 하는 가이드라인을 발표했습니다. 이러한 규제 당국의 승인은 RWE에 법적 뒷받침을 제공하고 규제 당국에 대한 신청과 시판 후 평가에 RWE를 사용하도록 장려하여 보다 증거에 기반한 건강 관리로 나아갈 수 있도록 합니다.
• 개인화 의료에 대한 수요 증가 : 개인화 의료에 대한 수요가 증가함에 따라 RWE의 필요성이 증가하고 있습니다. 다양한 집단에서 치료가 어떻게 진행되는지 파악함으로써, 이 정보를 통해 개인화된 치료 계획을 수립할 수 있습니다. 이러한 맞춤형 의료에 대한 수요가 RWE 솔루션에 대한 투자를 촉진하고 있습니다.
• 데이터 가용성 향상 : 전자건강기록(EHR), 웨어러블 기기 및 기타 디지털 헬스 기술의 보급으로 실제 데이터 가용성이 크게 증가하고 있습니다. 데이터 가용성이 높아짐에 따라 환자 결과, 치료 효과, 의료 이용률 등의 문제를 종합적으로 분석할 수 있게 되었습니다. 접근성이 향상되면 의료 서비스 개선에 도움이 되는 실용적인 인사이트를 얻을 수 있어 유용성이 높아집니다.
• 가치 기반 의료에 집중 : 가치 기반 의료 모델은 양보다 결과와 비용 효율성에 중점을 둡니다. 이러한 변화는 실제 환경에서 치료 효과, 환자 결과 및 비용 효율성에 대한 정보를 제공하는 RWE에 의해 뒷받침되고 있습니다. 가치 기반 진료에 대한 이러한 초점은 RWE를 개입의 가치를 입증하고 상환 결정을 촉진하는 도구로 채택하는 것과 일치합니다.

RWE 솔루션 시장의 도전과제는 다음과 같습니다.

• 데이터 품질 및 표준화 : 데이터 품질 및 표준화 : 데이터 품질 및 표준화는 RWE의 주요 과제 중 하나입니다. 데이터 형식의 불일치, 불완전한 기록, 다양한 데이터 수집 방법은 RWE의 신뢰성을 떨어뜨릴 수 있습니다. 이러한 문제를 해결하기 위해서는 표준화된 프로토콜을 개발하고 정확성과 사용 편의성을 향상시키기 위해 완전한 데이터 수집을 보장해야 합니다.
• 프라이버시 및 보안에 대한 우려 : 환자의 프라이버시 보호와 데이터 보안은 중요한 과제입니다. 이러한 민감한 자료의 사용이 증가함에 따라 개인 건강 정보 유출에 대한 우려가 커지고 있습니다. 환자 정보를 보호하고 RWE 솔루션에 대한 신뢰를 유지하기 위해서는 규제 요건과 강력한 보안 조치가 필요합니다.
• 다양한 데이터 소스의 통합 : EHR, 환자 등록, 웨어러블 기기 등 다양한 데이터 유형을 결합하면 이러한 정보의 통합과 관련된 문제가 발생합니다.

RWE 솔루션 시장은 기술 발전, 데이터 기반 인사이트에 대한 수요 증가, 규제 당국의 지원, 데이터 인프라에 대한 투자 및 협력에 힘입어 성장하고 있습니다. 그러나 규제 문제, 데이터 품질, 높은 기술 비용 등의 문제는 시장 역학에 영향을 미치며, RWE 솔루션이 발전하고 헬스케어 의사결정에 미치는 영향력을 강화하기 위해서는 이러한 촉진요인과 도전의 균형을 맞추는 것이 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 RWE(Real-World Evidence) 솔루션 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 RWE(Real-World Evidence) 솔루션 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 RWE(Real-World Evidence) 솔루션 시장 : 구성요소별
  • 서비스
  • 데이터세트
• 세계의 RWE(Real-World Evidence) 솔루션 시장 : 용도별
  • 의약품 개발과 승인
  • 의료기기 개발과 승인
  • 상환/보상 및 규제상 의사결정
  • 시판 후 안전성 및 유해 사례 모니터링
• 세계의 RWE(Real-World Evidence) 솔루션 시장 : 최종 용도별
  • 헬스케어 기업
  • 헬스케어 지불자
  • 헬스케어 제공자
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 RWE(Real-World Evidence) 솔루션 시장
• 북미의 RWE(Real-World Evidence) 솔루션 시장
• 유럽의 RWE(Real-World Evidence) 솔루션 시장
• 아시아태평양의 RWE(Real-World Evidence) 솔루션 시장
• 기타 지역의 RWE(Real-World Evidence) 솔루션 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 구성요소별 세계의 RWE(Real-World Evidence) 솔루션 시장 성장 기회
  • 용도별 세계의 RWE(Real-World Evidence) 솔루션 시장 성장 기회
  • 최종 용도별 세계 RWE(Real-World Evidence) 솔루션 시장 성장 기회
  • 지역별 세계의 RWE(Real-World Evidence) 솔루션 시장 성장 기회
• 세계의 RWE(Real-World Evidence) 솔루션 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 RWE(Real-World Evidence) 솔루션 시장 커패시티 확대
  • 세계의 RWE(Real-World Evidence) 솔루션 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• IQVIA
• IBM
• PPD
• Parexel
• PerkinElmer
• Icon Plc
• Oracle
• Syneos Health
• Cegedim Health Data
• Medpace

영문목차

Real-World Evidence Solution Trends and Forecast

The future of the global real-world evidence solution market looks promising with opportunities in the healthcare companies, healthcare payers, and healthcare providers markets. The global real-world evidence solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing industry need in the biosciences for improved Real-World Evidence (RWE) capabilities, the rise in the occurrence of chronic illnesses and cancer, and an increase in the use of cutting-edge technology for practical evidentiary solutions.

• Lucintel forecasts that within the application category, drug development & approval will remain the largest segment over the forecast period.
• Within the end-use category, healthcare companies will remain the largest segment due to the increasing significance of real-world evidence studies in the drug approval procedure.
• In terms of regions, North America will remain the largest region over the forecast period due to the increasing count of real-world evidence service providers and favorable government regulations.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Real-World Evidence Solution Market

The Real-World Evidence (RWE) Solution market is influenced by several emerging trends that reflect technological advancements and evolving healthcare needs. These trends are reshaping how real-world data is used to inform healthcare decisions.

• Artificial Intelligence and Machine Learning Integration: RWE analytics can be implemented with AI and ML technologies, which draw on vast health data to perform more efficiently. This improves prediction models by adding more precise parameters to the input of those models.
• Expansion of Data Sources: The range of RWE data sources is widening beyond traditional EHRs and claims to include new sources such as wearable devices, mobile health apps, and social media. This expansion allows for a more in-depth analysis of treatment outcomes and patient experiences in real life.
• Increased Emphasis on Patient-Centric Data: RWE solutions increasingly emphasize the use of patient-reported outcomes (PROs) or patient-centered endpoints (PCEs). PROs capture information from patients through surveys or wearable devices, providing insights into their preferences, quality of life, and treatment impact. This is making medicine more individualized and patient-centered.
• Regulatory Integration and Acceptance: Regulatory agencies have started including RWE in their decision-making systems, acknowledging its role in assessing drug safety, efficacy, and market access. This progress has led to faster approval processes and greater acceptance of RWE for regulatory purposes, often resulting in shorter timelines for new treatments to reach the market and better compliance with regulations.
• Focus on Data Security and Privacy: As the use of real-world data expands, there is a greater focus on ensuring its security. Improved algorithms to secure health data are essential, especially with regulations like GDPR and HIPAA, which require anonymization or encryption techniques. This helps foster trust in RWE solutions while upholding ethical standards in patient information management.

These emerging trends are reshaping the RWE Solution market by advancing data analysis capabilities, focusing on patient-centric approaches, expanding data sources, and increasing regulatory acceptance. The growth of collaborative ecosystems further supports the development and application of RWE solutions, driving innovation and improving decision-making in healthcare.

Recent Developments in the Real-World Evidence Solution Market

Recent developments in the RWE Solution market highlight advancements in technology, data integration, and regulatory practices. These developments are enhancing the effectiveness and scope of RWE solutions, impacting various aspects of healthcare.

• Integration of Advanced Analytics and Machine Learning: Integrating advanced analytics and machine learning with RWE solutions has significantly improved the ability to draw relevant inferences from large amounts of data. Machine learning algorithms can now detect complex patterns, predict patient outcomes, and identify trends that were previously hard to notice. Through this technology, personalized treatment plans are developed, providing more precise predictions and risk assessments, thereby improving decision-making. These advancements facilitate a deeper understanding of how treatments perform in various populations beyond controlled clinical trial settings.
• Enhanced Data Sources and Connectivity: Recent advances have broadened the types of data sources integrated into RWE solutions. Health systems, electronic health records (EHRs), wearable devices, and patient-reported outcomes now blend better together. This broader connectivity helps us understand patients' overall health status and the effects of treatment. By merging different data sets, healthcare providers get a more comprehensive picture of patients' experiences and treatment efficacy, supporting better-informed healthcare decisions for improved care.
• Regulatory Frameworks and Standardization: Progress is being made in developing regulatory frameworks and standards for RWE. Guidelines from organizations such as the FDA and EMA now include the use of real-world data during regulatory submissions. Quality control mechanisms are necessary for maintaining high standards in the development of regulatory practices using RWE, which enforces quality assessment procedures aimed at achieving reliable results. These standards enable harmonized practices for gathering information from patients worldwide, thus providing more credibility for conclusions drawn from RWE accepted by authorities when deciding on inclusion criteria.
• Patient-Centric Approaches and Engagement: Recently, there has been a focus on the direct involvement of patients in generating RWE. Patient-centric approaches, such as patient-reported outcomes (PRO) measures or actively engaging patients during data collection, are becoming more popular. This shows recognition of the importance of patients' own stories about their treatments. By considering patient feedback and preferences, health solutions can be customized to meet different needs, leading to more improved and personalized care strategies.
• Expansion of Real-World Evidence in Comparative Effectiveness Research: The use of RWE in comparative effectiveness research has increased to compare how well treatments work in usual clinical practice or other healthcare settings. RWE looks at how various therapies affect diverse patient populations and environments, which is critical for understanding actual outcomes. The expansion of RWE in this field helps identify the most effective treatments, optimize healthcare delivery, and support evidence-based clinical decision-making.

Recent developments in the RWE Solution market, including advancements in analytics, data integration, regulatory support, patient-centric data collection, and collaborative partnerships, are enhancing the effectiveness and scope of real-world evidence. These developments contribute to more informed decision-making and improved patient outcomes across healthcare systems.

Strategic Growth Opportunities for Real-World Evidence Solution Market

The RWE Solution market presents several strategic growth opportunities across key applications. Leveraging these opportunities can enhance decision-making and improve healthcare outcomes.

• Enhanced Patient-Centric Solutions: Developing enhanced patient-centric solutions represents a significant growth opportunity. This involves creating tools and platforms that focus on collecting and analyzing patient-reported outcomes and experiences. These solutions provide valuable insights into treatment effectiveness and patient satisfaction, driving improvements in personalized care.
• Advanced Analytics Platforms: There is an opportunity to expand advanced analytics platforms that leverage big data, AI, and machine learning. These platforms can offer more sophisticated data analysis and predictive capabilities, enabling healthcare stakeholders to derive actionable insights from real-world data and make informed decisions.
• Integrated Data Ecosystems: Building integrated data ecosystems presents a growth opportunity by combining data from various sources, including electronic health records, claims data, and wearable devices. This integration enhances the comprehensiveness and accuracy of RWE, supporting better decision-making and policy development.
• Regulatory Consulting Services: Providing regulatory consulting services focused on RWE offers growth potential. As regulatory agencies increasingly incorporate real-world data into decision-making, there is a need for expertise in navigating regulatory requirements and ensuring compliance. Consulting services can help organizations leverage RWE effectively for regulatory submissions and approvals.
• Collaboration Platforms for Data Sharing: Developing collaboration platforms for data sharing among healthcare providers, researchers, and technology companies is a strategic opportunity. These platforms facilitate the exchange of real-world data, promote joint research initiatives, and enhance the development of innovative RWE solutions.

Strategic growth opportunities in the RWE Solution market include enhanced patient-centric solutions, advanced analytics platforms, integrated data ecosystems, regulatory consulting services, and collaboration platforms for data sharing. These opportunities support the development and application of RWE solutions, driving market expansion and improving healthcare decision-making.

Real-World Evidence Solution Market Driver and Challenges

The Real-World Evidence (RWE) Solution market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory considerations. These elements shape market dynamics and impact the development and adoption of RWE solutions.

The factors responsible for driving the RWE solution market include:

• Technological Advancements: The fast pace of technological development, such as big data analytics, machine learning, and artificial intelligence, increases the ability to analyze large amounts of real-world data. These tools enable more accurate interpretations and offer insights that lead to better decision-making and personalized treatments. As technology advances, it also helps integrate different data sources and analyze them together, making RWE solutions more robust.
• Regulatory Support and Frameworks: Growing acceptance by regulatory agencies that real-world evidence must be included in decision-making processes has been a driving force. For example, the FDA and EMA have issued guidelines aimed at integrating RWE into drug approvals and market assessments. Such regulatory endorsements provide RWE with legal backing, encouraging its use in regulatory submissions and post-marketing evaluations, thus moving towards more evidence-based healthcare.
• Growing Demand for Personalized Medicine: The increasing demand for personalized medicine fuels the need for RWE. By revealing how treatments perform across diverse populations, this information allows for the formation of personalized treatment plans. This demand for customized care drives investments in RWE solutions.
• Increased Data Availability: The availability of real-world data has risen significantly due to the proliferation of electronic health records (EHRs), wearable devices, and other digital health technologies. More available data makes it possible to comprehensively analyze issues such as patient outcomes, treatment effectiveness, and healthcare utilization rates. Better accessibility enhances its usefulness by creating actionable insights that drive improvements in healthcare.
• Focus on Value-Based Healthcare: Value-based healthcare models emphasize outcomes and cost-effectiveness over volume. This shift is supported by RWE, which provides information about treatment effectiveness, patient outcomes, and cost efficiency in real-world settings. This focus on value-based care aligns with the adoption of RWE as a tool to prove the worthiness of interventions and facilitate reimbursement decisions.

Challenges in the RWE solution market include:

• Data Quality and Standardization: Ensuring data quality and standardization has been one of the main challenges in RWE. Variations in data formats, incomplete records, and diverse methods of data collection may make RWE less reliable. To address these issues, it is necessary to develop standardized protocols and ensure complete data collection for improved accuracy and usability.
• Privacy and Security Concerns: Protecting patient privacy and ensuring data security are critical challenges. Concerns about personal health information being disclosed due to more usage of such sensitive materials are prevalent. Regulatory requirements and robust security measures are necessary to safeguard patient information and maintain trust in RWE solutions.
• Integration of Diverse Data Sources: Combining various data types, such as EHRs, patient registries, and wearable devices, presents integration challenges associated with merging this information.

The RWE Solution market is driven by technological advancements, increased demand for data-driven insights, regulatory support, investment in data infrastructure, and collaborations. However, challenges related to regulatory concerns, data quality, and high technology costs impact market dynamics. Balancing these drivers and challenges is essential for advancing RWE solutions and enhancing their impact on healthcare decision-making.

List of Real-World Evidence Solution Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-world evidence solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-world evidence solution companies profiled in this report include-

• IQVIA
• IBM
• PPD
• Parexel
• PerkinElmer
• Icon Plc
• Oracle
• Syneos Health
• Cegedim Health Data
• Medpace

Real-World Evidence Solution by Segment

The study includes a forecast for the global real-world evidence solution by component, application, end use, and region.

Real-World Evidence Solution Market by Component [Analysis by Value from 2018 to 2030]:

• Services
• Data Sets

Real-World Evidence Solution Market by Application [Analysis by Value from 2018 to 2030]:

• Drug Development & Approvals
• Medical Device Development & Approvals
• Reimbursement/Coverage & Regulatory Decision Making
• Post Market Safety & Adverse Events Monitoring

Real-World Evidence Solution Market by End Use [Analysis by Value from 2018 to 2030]:

• Healthcare Companies
• Healthcare Payers
• Healthcare Providers
• Others

Real-World Evidence Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Real-World Evidence Solution Market

The Real-World Evidence (RWE) Solution market is evolving rapidly as healthcare stakeholders increasingly seek insights from real-world data to improve decision-making and patient outcomes. Advances in technology, data analytics, and regulatory changes are driving the development of RWE solutions, influencing various regions differently. Here's a look at recent developments in key markets: the United States, China, Germany, and India.

• United States: RWE solutions in the US have evolved to incorporate advanced analytics and artificial intelligence (AI), leading to better data insights. The FDA has increasingly embraced RWE in regulatory decisions, paving the way for the use of EHRs and claims data for drug approvals as well as post-market surveillance. Additionally, many tech companies are partnering with health facilities to enhance interoperability among different healthcare systems and improve patient outcomes. Investments in cloud computing and machine learning have further strengthened the functionality of RWE, enabling organizations to obtain more accurate results.
• China: China's RWE solutions have made significant advances due to rapidly growing data collection and analysis technologies. The government is expected to rely more on RWE in its drug approval processes and healthcare policy development, particularly through projects such as the 13th Five-Year Plan on Drug Safety. Investments in big data analytics and AI technology have increased the capacity to analyze large volumes of EHRs and patient registries. Initiatives include increased collaboration between Chinese tech companies and healthcare institutions, leading to better data integration. Furthermore, regulatory bodies in China are increasingly embracing RWE in their decision-making processes.
• Germany: Data protection laws, along with the country's emphasis on advanced analytics, have enabled Germany to make significant strides toward RWE solutions. The robustness of Germany's e-health databases, combined with a strong focus on privacy, facilitates these applications by ensuring strict adherence to regulations concerning the storage, sharing, and dissemination of personal medical information. Recent developments include the use of AI and machine learning to analyze patient records and optimize clinical trial designs. Additionally, national initiatives promoting RWD for evidence-based healthcare decisions and policies have enhanced Germany's capacity for health research.
• India: In India, RWE solutions are advancing through increased investments in digital healthcare infrastructure and data analytics. Initiatives such as the National Digital Health Mission aim to promote the use of RWE for health reforms and improved patient care. With better data collection through EHRs and health information systems, there is a greater ability to track public health trends. Additionally, many local tech start-ups are collaborating with international pharmaceutical companies to accelerate the deployment of RWE in drug discovery and healthcare policy-making.

Features of the Global Real-World Evidence Solution Market

Market Size Estimates: Real-world evidence solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-world evidence solution market size by component, application, end use, and region in terms of value ($B).

Regional Analysis: Real-world evidence solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different component, application, end use, and regions for the real-world evidence solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-world evidence solution market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the real-world evidence solution market by component (services and data sets), application (drug development & approvals, medical device development & approvals, reimbursement/coverage & regulatory decision making, and post market safety & adverse events monitoring), end use (healthcare companies, healthcare payers, healthcare providers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-World Evidence Solution Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Real-World Evidence Solution Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Real-World Evidence Solution Market by Component
  • 3.3.1: Services
  • 3.3.2: Data Sets
• 3.4: Global Real-World Evidence Solution Market by Application
  • 3.4.1: Drug Development & Approvals
  • 3.4.2: Medical Device Development & Approvals
  • 3.4.3: Reimbursement/Coverage & Regulatory Decision Making
  • 3.4.4: Post Market Safety & Adverse Events Monitoring
• 3.5: Global Real-World Evidence Solution Market by End Use
  • 3.5.1: Healthcare Companies
  • 3.5.2: Healthcare Payers
  • 3.5.3: Healthcare Providers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Real-World Evidence Solution Market by Region
• 4.2: North American Real-World Evidence Solution Market
  • 4.2.1: North American Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
  • 4.2.2: North American Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
• 4.3: European Real-World Evidence Solution Market
  • 4.3.1: European Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
  • 4.3.2: European Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
• 4.4: APAC Real-World Evidence Solution Market
  • 4.4.1: APAC Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
  • 4.4.2: APAC Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
• 4.5: ROW Real-World Evidence Solution Market
  • 4.5.1: ROW Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
  • 4.5.2: ROW Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Real-World Evidence Solution Market by Component
  • 6.1.2: Growth Opportunities for the Global Real-World Evidence Solution Market by Application
  • 6.1.3: Growth Opportunities for the Global Real-World Evidence Solution Market by End Use
  • 6.1.4: Growth Opportunities for the Global Real-World Evidence Solution Market by Region
• 6.2: Emerging Trends in the Global Real-World Evidence Solution Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Real-World Evidence Solution Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-World Evidence Solution Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: IQVIA
• 7.2: IBM
• 7.3: PPD
• 7.4: Parexel
• 7.5: PerkinElmer
• 7.6: Icon Plc
• 7.7: Oracle
• 7.8: Syneos Health
• 7.9: Cegedim Health Data
• 7.10: Medpace